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Abstract:  Transformation  of  macrophages  to  foam cells  is  determined by  the  rates  of 
cholesterol uptake and efflux. This study uses a real time RT-PCR technique to investigate 
the role of conjugated linoleic acid (CLA), α-linolenic acid (ALA) and eicosapentaenoic 
acid  (EPA)  in  the  regulation  of  the  ATP-binding  cassette  A1  (ABCA1)  and  liver  X 
receptor α (LXR) genes, which are involved in cholesterol homeostasis. Accordingly, these 
fatty acids significantly reduced the total, free and esterified cholesterols within the foam 
cells. While the expression of the ABCA1 and LXRα genes was increased in the presence 
of  the  pharmacological  LXRα  ligand,  T0901317,  their  mRNA  expression  was  not 
significantly  affected  by  CLA,  ALA  and  EPA.  These  results  suggest  that  although 
polyunsaturated fatty acids have an effect on cholesterol homeostasis, they cannot change 
the expression of the ABCA1 and LXRα genes. Alternatively, several other genes and 
proteins may be involved. 
Keywords:  THP-1;  conjugated  linoleic  acid;  α-linlenic  acid;  eicosapentaenoic  acid;  
liver X receptor α; ATP-binding cassette A1  
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1. Introduction  
Accumulation  of  cholesterol  in  the    walls  of  arteries  provides  the  possibility  of  the  uptake  of 
modified  low-density  lipoprotein  (m-LDL)  by  macrophages  and  hence,  promotes  a  local  
pro-inflammatory response leading to a pathologic condition known as atherosclerosis [1]. The balance 
of cholesterol uptake and efflux in macrophages is a determining factor towards the formation of foam 
cells, which play a key role in the initiation and progression of atherosclerosis. Numerous genes and 
proteins,  such  as  ATP-binding  cassette  A1  (ABCA1),  liver  X  receptors  (LXRs),  sreol  regulatory 
element  binding  proteins  (SREBPs)  and  Peroxisome  proliferator-activated  receptors  (PPARs),  are 
involved  in  the  process  of  foam  cell  formation,  and  study  of  these  factors  and  their  regulatory 
mechanisms is of great value for the prevention of cardiovascular disease (CVD). ABCA1 belongs to 
the large ATP-binding cassette transporter family. These transmembrane proteins transport cholesterol 
and phospholipids to lipid-free or lipid-poor apolipoprotein A-I (apoA-I). In fact, ABCA1, whose 
function is defective in Tangier disease, is a pivotal protein in regulation of plasma HDL-cholesterol 
levels and cellular cholesterol homeostasis [2–5]. 
Clinically, patients who are homozygous for Tangier disease accumulate macrophage-derived foam 
cells  in  various  tissues.  Several  independent  studies  have  demonstrated  that  ABCA1  is  directly 
regulated by LXRs [6–9]. Also, several factors such as n-3 polyunsaturated fatty acids (PUFAs) have 
been shown to be able to regulate the expression of the ABCA1 gene, and hence, affect the cellular 
cholesterol  efflux  [10].  ω-3  PUFAs  are  also  known  to  confer  various  health  benefits,  including 
increased insulin signaling [11], enhanced immune response [12,13], decreased plasma lipid levels 
[14,15], and finally decreased incidence of lung [16] and cardiovascular [17–19] diseases. In addition, 
conjugated linoleic acids (CLAs) are new potent anti-atherogenic dietary fatty acids in animal models 
of atherosclerosis and are capable of activating PPARs in vitro and in vivo [20]. Hu et al. showed that 
ω-3 PUFA can inhibit cholesterol efflux in THP-1 macrophage foam cells by promoting degradation of 
ABCA1 protein [21].  
Liver  X  receptors  (LXRα  and  LXRβ)  are  class  II  nuclear  receptors  that  directly  bind  to  the 
nucleotide  repeats  (LXRE  sequence)  as  a  heterodimer  with  Rethinoid  X  Receptor  (RXR)  [22]. 
Oxysterols, like 22(R)-hydroxycholesterol and 24,25-epoxycholesterol, have been shown to bind and 
activate the LXRs [23–25]. This activation leads to the binding of LXR/RXR heterodimers to LXRE 
sequences within the promoters of genes whose products are involved in hepatic bile acid synthesis, 
e.g., 7-hydroxylase (Cyp7A), and hence the main route for elimination of cholesterol from the body is 
activated. Moreover, LXRα limits the accumulation of cholesterol esters by inducing the expression of 
the ABCA1 and ABCG1 genes [6,9,26,27]. Joseph et al. showed that activation of LXR inhibited the 
development  of  atherosclerosis  in  mice  [28]  and  some  studies  proposed  the  stimulant  role  of 
unsaturated fatty acids (USFAs) for LXRα but not LXRβ in cultivated hepatoma cells [29]. However, 
in contrast to these reports, other researchers believe that USFAs suppress the expression of the LXR 
gene  [30].  Furthermore,  PUFAs  are  found  to  compete  with  oxysterols  for  binding  to  LXRα,  and 
thereby to suppress oxysterol-induced upregulation of SREBP-1c [24]. In the whole cell, it has been 
shown that eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids decrease the cellular content of 
cholesterol-ester (CE) to approximately 50%, while this rate of decrease for some other fatty acids, 
like ω-3 linolenic, ω-6 linoleic and arachidonic acid,s drops to around 16%, compared to palmitic, Int. J. Mol. Sci. 2010, 11                       
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stearic, or oleic acids. In fact, EPA is a poor substrate for esterification that reduces the incorporation 
of oleic acid into CE by up to 50%, whereas arachidonic, palmitic, stearic, and linolenic acids don’t 
have such an effect [31]. Accordingly, when human fibroblasts were grown in the presence of EPA for 
five days, both FC and CE levels were reduced in comparison with control and linoleic acid-treated 
cells [32].  
Collectively, based on the mentioned reports, the role of ABCA1 and LXR towards the formation of 
foam cells is still a matter of debate. Therefore, with the final aim of studying the effect of expression 
of these two genes on the formation of foam cells, this study sought to address the influence of several 
distinct  polyunsaturated  fatty  acids  upon  the  transcription  level  of  ABCA1  and  LXRα  genes  in 
macrophages and additionally upon the cholesterol homeostasis in foam cells.  
2. Results and Discussion 
2.1. Toxicology Assay 
As the first step, we sought to confirm that the selected fatty acids have no toxicity on the THP-1 
cells. To this end, XTT assay was performed in the presence of the different fatty acids CLA, ALA and 
EPA, in addition to T0901317 as the LXRα ligand. The results showed that fatty acids and T091317 
have no adverse effect on the viability of THP-1 cell line, in comparison with control group (Figure 1). 
Figure 1. Assessment of cell viability by XTT assay. The presence of 100 µM conjugated 
linoleic acid (CLA), α-linolenic acid (ALA) and eicosapentaenoic acid (EPA) and 1 µM 
T0901317  was  not  toxic  to  the  THP-1  cells,  in  comparison  with  the  control  group 
(DMSO). Data represent mean ± SD of at least three experiments performed in triplicate.  
 
2.2. Effect of Fatty Acids Treatment on the Expression of LXRα and ABCA1 Genes in THP-1-Derived 
Macrophage Foam Cells 
At the next step, to provide the possibility to do our analysis on human macrophages, THP-1 cells, a 
human  monocytic  line  were  fully  differentiated  into  macrophages  by  exposure  to  100  ng/mL  of 
phorbol 12-myristate 13-acetate (PMA) for 72 h. Before cholesterol loading, THP-1 macrophages were 
initially pretreated for 24 h with either ALA, c9,t11-CLA, or EPA (100 µM each) or T901317 (1 µM) Int. J. Mol. Sci. 2010, 11                       
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as the control vehicle. Cells were then loaded with 50 µg/mL Ac-LDL in SFM medium for 48 h to 
induce foam cell transformation and incubated in the presence of fatty acids or pharmacological ligand 
of  LXRα  for  a  further  48  h.  Results  indicated  that  ABCA1  mRNA  expression  in  THP-1-derived 
macrophage foam cells was not considerably affected by CLA, ALA and EPA fatty acid treatments  
(P  =  0.82,  P  =  1.0  and  P  =  0.736,  respectively),  while  the  T901317  significantly  increased  the 
expression (Figure 2).  
Figure 2. Effects of fatty acids (100 µM) and T0901317 (pharmacological LXRα ligand) 
on mRNA levels of the ABCA1 gene in THP-1-derived macrophage foam cells. THP-1-
derived differentiated macrophages were initially pretreated for 24 h with either fatty acids 
or T0901317. Cells were then loaded with 50 µg/mL Ac-LDL in SFM medium for 48 h to 
induce foam cell transformation and incubated in the presence of fatty acids or T0901317 
for a further 48 h. mRNA levels were analyzed by cyber green system. The values were 
normalized with respect to the level of β-actin mRNA. Results represent means ± SD from 
triplicate  determinations,  representative  of  3  independent  experiments  compared  with 
control.  Statistical  difference  in  comparison  with  the  control  group  was  analyzed  by  
one-way ANOVA followed by Tukey multicomparison test. *P < 0.05. 
 
 
Furthermore, the mRNA expression level of the LXRα gene in THP-1-derived macrophage foam 
cells  was  not  significantly  changed  by  treatment  with  100  µM  CLA,  ALA  and  EPA  fatty  acid 
compared  to  the  cells  treated  with  control  DMSO,  while  T901317  significantly  increased  the 
expression (P = 0.65, P = 0.85 and P = 0.202, respectively) (Figure 3). 
T0901317,  the  pharmacological  ligand  of  LXR,  was  used  as  the  positive  control  in  these 
experiments. As expected, this compound significantly increased the mRNA expression levels of both 
the LXRα and ABCA1 genes in THP-1-derived macrophage foam cells, when compared with the 
control cells.  
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Figure 3. Effect of fatty acids (100 µM) and T0901317 (pharmacological LXRα ligand) on 
LXRα  mRNA  levels  in  THP-1-derived  macrophage  foam  cells.  THP-1-derived 
differentiated macrophages were initially treated for 48 h with fatty acids or T0901317. 
Cells were then loaded with 50 µg/mL of Ac-LDL in SFM medium for 48 h to induce 
foam cell transformation, and incubated in the presence of fatty acids or pharmacological 
ligand for a further 48 h. mRNA levels were analyzed by cyber green system. The values 
were normalized with regard to the β-actin mRNA level. Results represent means ± SD 
from triplicate determinations, representative of 3 independent experiments compared with 
control.  Statistical  difference  in  comparison  with  the  control  group  was  analyzed  by  
one-way ANOVA followed by Tukey multicomparison test. *P < 0.05. 
 
2.3. Distribution of Total Cellular Cholesterol in Cholesterol-Loaded Macrophages 
THP-1-derived differentiated macrophages, initially pre-treated with either fatty acids or T901317, 
were loaded  with  50 µg/mL  of Ac-LDL  for 48  h and transformed to foam cells. Their  increased 
cholesteryl ester content was reflected in the increased number of Oil Red-O staining lipid droplets 
(Figure 4). These THP-1-derived macrophage foam cells were then incubated with either 100 µM of 
fatty acids or 1 µM of T901317 for a further 48 h to determine the possible effects of fatty acids and 
T901317 on the concentration of intracellular total cholesterol (TC) and distribution of cholesterol 
forms  as  free  cholesterol  (FC)  and  cholesteryl  ester  (CE).  The  result  demonstrated  a  significant 
decrease in intracellular concentration of TC, FC, and CE in comparison with not treated control foam 
cells (P ≤ 0.05) (Figure 5).  
These  results  clarify  the  role  of  polyunsaturated  fatty  acids  and  activation  of  LXRα  in  the 
significant  decrease of total cellular cholesterol in foam cells. Moreover, this study explained  the 
effects of EPA, ALA and CLA on the cellular lipid distribution and the expression of ABCA1 and 
LXRα genes. 
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Figure 4. Transformation of macrophages to foam cells. THP1-derived macrophages (A) 
were incubated for 48 h in the presence of Ac-LDL-containing SFM medium (50 µg/mL). 
Lipid accumulation in THP-1-derived macrophages transformed them to foam cells that 









Figure  5.  The  effect  of  fatty  acids  and  T901317  compound  on  the  concentration  of 
intracellular  cholesterol  as  total  cholesterol  (A),  free  cholesterol  (B)  and  esterified 
cholesterol (C) levels. THP-1-derived macrophages were cholesterol-loaded with Ac-LDL 
(50 µg/mL) for 48 h. Fatty acids and T0901317 were separately added to these cells 24 h 
before  cholesterol-loading  and  thereafter  every  24  h.  TC  and  FC  were  enzymatically 
determined, and CE level was calculated as the difference between TC and FC amounts. 
Results show the mean ± SD of three independent experiments. Statistically significant 
differences between different groups are obtained by one-way ANOVA analysis followed 
by Tukey multicomparison test. Compared with untreated control group (foam cells), all 
treated groups illustrate a significant decrease (*p ≤ 0.05).  
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In the arterial intima, after monocytes are recruited, they obtain the morphological characteristics of 
macrophages and then accumulate cholesteryl esters (CE) as cytoplasmic droplets to guide foam cell 
formation. One of the most important factors in prevention of above phenomena is cholesterol efflux 
via ABCA1. Several  independent  studies  have demonstrated that  ABCA1 is directly regulated  by 
LXRα [6–9] and that PUFAs are the activating ligands for LXRα. In the present study, we showed that 
PUFA has no significant effect on ABCA1 and LXRα gene expression in human THP-1 macrophage-
derived  foam  cells,  however,  incubation  of  THP-1  derived  foam  cells  with  fatty  acids  led  to  the 
reduction of TC, CE and FC levels. Of note, EPA and ALA non-significantly lowered the expression 
of the ABCA1 gene, while CLA showed a trend for higher expression (Figure 2). Similar results were 
observed in case of the mRNA expression of the LXRα gene as well (Figure 3). There are several 
conflicting data regarding the effect of PUFA on the transcription level of LXR: Uehara et al. reported 
no effect on the mRNA levels of LXRα or RXR [33], while other researchers demonstrated either the 
stimulatory [29] or suppressive [30] effects on the LXRα gene expression. Moreover, fatty acids have 
been shown to activate the PPARα and γ [34], which indirectly increases the ABCA1 gene expression 
by positive regulation of the LXRα gene.  Int. J. Mol. Sci. 2010, 11                       
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The  intracellular  mechanisms  of  cholesterol  homeostasis  are  complex  and  various  factors  are 
involved.  As  so,  recent  studies  indicate  that  PPARα  stimulates  post-lysosomal  mobilization  of 
cholesterol [35] and unsaturated fatty acids activate the ABCA1 at the protein level and induce the 
LXRα and ABCA1 genes to enhance their transcription levels [36]. Fatty acids are shown to activate 
PPARα and PPARγ, as well [37]. Accordingly, Hirakata et al. have proposed that PPARγ ligands 
reduce the CE accumulation in macrophages by induction of CEH (cholesterol ester hydrolase, whose 
product enzymatically hydrolyzes the CE to free cholesterol and fatty acids) and inhibition of ACAT-1 
(acyl-CoA:cholesterol  acyltransferase-1,  whose  product  catalyzes  cholesterol  ester  formation  from 
cholesterol and fatty acyl-CoA) genes expression [38]. From the other side, Davis has shown that ω–3 
polyunsaturated fatty acids significantly reduce the rate of cholesterol esterification in macrophages, 
most  likely  due  to  the  inhibition  of  ACAT-1  [39].  Another  factor  involved  is  CD36,  which  is  a  
multi-ligand scavenger receptor on the surface of monocytes/macrophages. This molecule causes the 
endocytosis of the modified LDL (m-LDL), which leads to the formation of foam cells. Interestingly, 
ω-3 fatty acids have been shown to reduce CD-36 expression at the gene and protein levels, which in 
turn prevents the formation of macrophage foam cells [40]. 
It  is  noteworthy  that  SR-B1,  which  belongs  to  the  class  B  scavenger  receptor  family,  has  the 
capability to bind m-LDL, as well. This receptor has gained importance due to its role in reverse 
cholesterol  transport,  and  since  it  is  involved  in  cholesterol  efflux  in  macrophages,  it  may  be 
considered as a possible therapeutic intervention point for researchers. Studies demonstrate that SR-B1 
is  a  target  for  being  regulated  by  PPARs  [41].  As  mentioned,  PUFAs  can  active  PPARs  gene 
expression  and  therefore,  they  may  indirectly  increase  the  expression  of  SR-B1  and  enhance  the 
cellular cholesterol efflux in macrophages-derived foam cells. 
Taken together, our results - in accordance with the mentioned findings - suggest that free PUFAs 
possibly reduce the CE concentration within the foam cells and hence, can affect the development of 
arthrosclerosis. Moreover, we found that cholesterol homeostasis is not just affected by factors like 
ABCA1 and LXR, but the complicated interaction of different factors, which were mentioned above, 
as well. Therefore, investigating the effect of fatty acids on one gene does not result in a distinct 
conclusion, as the available reports also rely on the interaction of multiple factors, which should be 
studied in more detail. 
3. Materials and Methods  
3.1. Chemicals 
T0901317  (pharmacological  LXRα  ligand),  phorbol  12-myristate  13-acetate  (PMA),  dimethyl 
sulfoxide (DMSO), linoleic acid, eicosapentaenoic acid and conjugated linolenic acid were obtained 
from Sigma-Aldrich, USA. Phosphate buffered saline (PBS) tablets were obtained from Takara, Japan. 
Reagents for RNA extraction and reverse transcription were obtained from Qiagen, Germany. All 
other chemicals were obtained from Sigma-Aldrich, USA. 
3.2. Cell Culture 
Human monocytic THP-1 cell line was obtained from national cell bank of Iran (Pasteur institute, 
Iran), cultured at 1.0 × 10
6 cells per well in 6-well plates and maintained in RPMI 1640 medium Int. J. Mol. Sci. 2010, 11                       
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(Invitrogen,  USA)  supplemented  with  10%  heat  inactivated  fetal  bovine  serum  (FBS),  sodium 
pyruvate, 1 mM L-glutamine, 30 µL/mL amphotricin B, 100 µg/mL streptomycin, 100 U/mL penicillin 
and 100 µM 2-mercaptoethanol at 37 °C in a humidified atmosphere of 5% CO2. To differentiate 
monocytes into macrophages, THP-1 cells were washed with serum free RPMI 1640, resuspended in 
SFM (serum free medium) containing PMA (100 ng/mL) and cultured for 3 days [42].  
3.3. Isolation and Acetylating of LDL 
LDL was isolated from human plasma by density gradient ultracentrifugation at 200,000 g for 10 h 
at  4  °C,  as  previously  described  [43].  LDL-protein  concentration  was  determined  using  Bradford 
assay.  Isolated  LDL  was  additionally  acetylated  by  saturated  sodium  acetate  and  acetate  
anhydride [44].  
3.4. Oil Red-O Staining 
For transformation of macrophages to foam cells, THP1-derived macrophages were incubated for 
48 h in the presence of Ac-LDL-containing SFM medium (50 µg/mL). Cells were fixed and stained 
with Oil Red O, as previously described [45]. 
3.5. Fatty Acids and T0901317 Treatment 
All  fatty  acids  including  Conjugated  Linoleic  Acid  (CLA),  α-Linolenic  Acid  (ALA),  and 
Eicosapentaenoic Acid (EPA) in addition to T0901317 compound were prepared in DMSO. THP-1-
derived  macrophages  were  pretreated  with  fatty  acids  and  T0901317  for  24  h  (final 
concentration ≤0.01%) and then transformed to foam cells by incubation with 50 µg/mL of Ac-LDL. 
3.6. RNA Isolation and Real-Time RT-PCR 
Total  cellular  RNA  was  extracted  using  the  RNeasy  kit  (Qiagen,  Germany),  according  to  the 
manufacturer’s  protocol.  cDNAs  were  synthesized  from  1  µg  of  extracted  RNA  using  quantitect 
reverse transcriptase kit (Qiagen, Germany). Constructed cDNAs were quantitatively PCR-amplified 
using  SYBRgreen  detection  system  in  an  ABI  PRISM  7900HT  instrument.  The  result  for  each 
template was normalized relative to the obtained amount for β-Actin expression. 
3.7. Toxicology Assay 
Viability  of  the  cells  treated  with  100  µM  fatty  acid  and  1  µM  T0901317  was  quantified 
spectrophotometrically  by  2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-S-(phenylamino)  carbonyl-2-
tetrazolium  hydroxide  (XTT)  assay  (Sigma-Aldrich),  as  described  by  Scudiere  et  al. [46].  THP-1 
macrophages  were  cultured  with  or  without  the  fatty  acids  and  T0901317  for  24  h  in  a  96-well 
microplate. After an appropriate incubation (37 °C, 4 h) with XTT, plates were shaken and absorbance 
was measured at 450 nm. Results were expressed as the percentage of cell viability with respect to the 
control negative absorbance (100% cell viability).  
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3.8. Intracellular Cholesterol Measurement  
Differentiated  THP-1  macrophages  were  cultured  in  SFM  and  pre-treated  with  fatty  acids  and 
T0901317 for 24 h. These cells were then treated with 50 µg/mL of ac-LDL and incubated in the 
presence of fatty acids or T0901317 for 48 h. After washing twice with PBS and homogenization in 
200 µL of hexane-isopropanol (3:2) [47], the organic phase was used for free and total cholesterol 
measurements by enzymatic assays (Calbiochem, USA). Esterified cholesterol was also measured as 
the difference between total and free cholesterol. Cells were lysed with RIPA buffer (0.1% SDS,  
100 mg/mL PMSF, 0.5% sodium deoxycholate, 10 mM sodium phosphate, 150 mM NaCl, 30 mg/mL 
aprotinin, 1 mM sodium orthovanadate and 50 mg/mL Dithiotrithol, pH 7.4) [48] and cellular protein 
was measured by Bradford assay [49]. Results were presented as µg lipids/mg cellular proteins.  
3.9. Statistical Analysis 
All results are presented as means ± S.D. Differences among groups were determined by one-way 
ANOVA, with Post-Hoc comparison by Tukey multiple comparison test. The level of significance for 
all statistical analyses was set at p < 0.05. Analyses were performed using SPSS on Windows software. 
4. Conclusion 
In conclusion, while this study suggests a role of fatty acids toward the reduction of cholesterol 
accumulation within the foam cells, it excluded the distinct role of ABCA1 and LXRα in this process. 
Therefore, it could be concluded that fatty acids might imply their effect through other pathways such 
as PPARs. The process of lipid metabolism within the foam cells seems to be very complicated, and 
this  fact  can  explain  the  controversial  results  that  are  reported  by  different  research  groups. 
Accordingly,  detailed  evaluation  of  other  involved  genes  and  factors  at  the  same  time  will  
be necessary. 
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